There were no loans or costs to the company for this transaction. The director has allocated this stock for use in advancing the company’s strategic initiatives, thereby preventing further dilution.
“Our director’s purchase of these shares is a major accomplishment in positioning
Strategic Use of Shares
The director is committed to utilizing the acquired shares to support moving the company forward and continuing the trend of non-dilution which the company has upheld since September of 2023.
Upcoming Shipment and Innovation
In addition to this significant transaction,
About
Our recent patent underscores our innovation-driven ethos, detailing novel methods for bacterial detection and nutrient delivery using mycelium. This patent stands as a testament to our commitment to intertwining age-old wisdom with contemporary technological advancements, aiming to revolutionize healthcare interventions and amplify overall well-being. Inspired by the vision and resilience of mycology pioneers,
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
Corporate Contact
CEO: Kimberly Carlson
Tel: (239) 273-1194
Email: info@mushroomsinc.com
Website: www.mushroomsinc.com
For additional information about our products, initiatives, and partnerships, please visit our website or contact our investor relations department.
Prior Press Releases
Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses withGerman Partnership , and Boosts Engagement InitiativesMushrooms Inc. (OTC:MSRM) expands on full patent filing for Nutrient-Delivery Textile Innovation, MYCOThread- Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery
- Announces Diverse Business Development Team Assembled to Drive Company Growth
- Poised for Textile Innovation and
Global Impact as Full Patent Filing for Mycelium Thread Nears Completion - CEO,
Kimberly Carlson , Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast - Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders
Mushrooms, Inc. AnnouncesName and Ticker Symbol Change on O_T_C_ _M_a_r_k_e_t_s_ _t_o_ _“M_S_R_M_” _
Link to our Monthly Newsletters: Monthly Newsletters for
Wire Service Contact:
IBN
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
![](https://ml.globenewswire.com/media/NDE4ODNkMmYtYjVkNy00YjNkLWI5OTEtNzgzNzY1ZTliMjkzLTUwMDExNzU1Mw==/tiny/Mushrooms-Inc-.png)
2024 GlobeNewswire, Inc., source